Position in INBX
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$109,713,488
+$31,866,124 QoQ
Shares Held
1,157,926
0.0% QoQ
Ownership
7.87%
of shares outstanding
% of Portfolio
20.54%
of 13F equity value
Holder Rank
#3
of 161 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INBX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Sanofi holds $534,041,658 across 10 Biotechnology names. INBX ranks #2 (20.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MGTX |
MeiraGTx Holdings plc
|
12,197,737 | $164,791,426 | |
| 2 | INBX |
Inhibrx Biosciences, Inc.
This page
|
1,157,926 | $109,713,488 | |
| 3 | NVAX |
Novavax Inc
|
6,880,481 | $64,814,131 | |
| 4 | ANAB |
Anaptysbio, Inc
|
821,917 | $55,479,397 | |
| 5 | ODTX |
Odyssey Therapeutics, Inc.
|
1,991,918 | $37,268,785 | |
| 6 | AGMB |
Agomab Therapeutics NV
|
2,783,096 | $36,124,586 | |
| 7 | MPLT |
MapLight Therapeutics, Inc.
|
912,041 | $32,687,549 | |
| 8 | TRAX |
First Tracks Biotherapeutics, Inc.
|
821,917 | $16,536,970 |
All Filings in INBX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $109,713,488 | 1,157,926 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $77,847,364 | 1,157,926 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $91,476,154 | 1,157,926 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $38,998,947 | 1,157,926 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $16,523,604 | 1,157,926 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $16,199,384 | 1,157,926 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $17,832,060 | 1,157,926 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||